Key Highlights
- Novo Nordisk is suing Hims & Hers for copyright infringement.
- The lawsuit targets unapproved versions of Wegovy and Ozempic.
- Novo Nordisk seeks a ban on Hims & Hers selling these knockoffs.
Novo Nordisk has had it up to here with knockoff Ozempic
Novo Nordisk has filed a lawsuit against Hims & Hers, seeking to stop the telehealth provider from selling unapproved knockoff versions of its weight-loss medications, Wegovy and Ozempic. The company alleges copyright infringement due to the sale of cheaper alternatives.
Loading ad...
Loading ad...
Sources
This quick summary is automatically generated using AI based on reports from multiple news sources. The content has not been reviewed or verified by humans. For complete details, accuracy, and context, please refer to the original published articles.
